| Dr Omar Mohammad Ibrahim, MD | |
|
263 Farmington Ave, Farmington, CT 06030-0001 | |
| (860) 679-8300 | |
| (860) 679-8344 |
| Full Name | Dr Omar Mohammad Ibrahim |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 18 Years |
| Location | 263 Farmington Ave, Farmington, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487853941 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 53313 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| John Dempsey Hospital | Farmington, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Connecticut Health Center | 3678472016 | 523 |
News Archive
Pfizer Inc. (NYSE:PFE) announced today top-line results from a Phase 3B/4 study of RAPAMUNE® (sirolimus) evaluating kidney transplant patients who transitioned from tacrolimus-based therapy (TAC) to RAPAMUNE® 3 to 5 months after transplant.
Research shows that many treatments can help prevent migraine in certain people, yet few people with migraine who are candidates for these preventive treatments actually use them, according to new guidelines issued by the American Academy of Neurology.
A new study by researchers at UCLA shows that even a short-term visit to a severely polluted city can be detrimental to one's health.
The National Institute for Neurological Disorders and Stroke (NINDS) has selected Columbia University College of Physicians and Surgeons and Weill Cornell Medical College to participate in a new national effort to accelerate the development of therapies for people with neurological diseases.
› Verified 1 days ago
| Entity Name | University Of Connecticut Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720083769 PECOS PAC ID: 3678472016 Enrollment ID: O20040106000105 |
News Archive
Pfizer Inc. (NYSE:PFE) announced today top-line results from a Phase 3B/4 study of RAPAMUNE® (sirolimus) evaluating kidney transplant patients who transitioned from tacrolimus-based therapy (TAC) to RAPAMUNE® 3 to 5 months after transplant.
Research shows that many treatments can help prevent migraine in certain people, yet few people with migraine who are candidates for these preventive treatments actually use them, according to new guidelines issued by the American Academy of Neurology.
A new study by researchers at UCLA shows that even a short-term visit to a severely polluted city can be detrimental to one's health.
The National Institute for Neurological Disorders and Stroke (NINDS) has selected Columbia University College of Physicians and Surgeons and Weill Cornell Medical College to participate in a new national effort to accelerate the development of therapies for people with neurological diseases.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Omar Mohammad Ibrahim, MD 263 Farmington Ave, Farmington, CT 06030-2212 Ph: (860) 679-8300 | Dr Omar Mohammad Ibrahim, MD 263 Farmington Ave, Farmington, CT 06030-0001 Ph: (860) 679-8300 |
News Archive
Pfizer Inc. (NYSE:PFE) announced today top-line results from a Phase 3B/4 study of RAPAMUNE® (sirolimus) evaluating kidney transplant patients who transitioned from tacrolimus-based therapy (TAC) to RAPAMUNE® 3 to 5 months after transplant.
Research shows that many treatments can help prevent migraine in certain people, yet few people with migraine who are candidates for these preventive treatments actually use them, according to new guidelines issued by the American Academy of Neurology.
A new study by researchers at UCLA shows that even a short-term visit to a severely polluted city can be detrimental to one's health.
The National Institute for Neurological Disorders and Stroke (NINDS) has selected Columbia University College of Physicians and Surgeons and Weill Cornell Medical College to participate in a new national effort to accelerate the development of therapies for people with neurological diseases.
› Verified 1 days ago
Maroun Sfeir, Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 263 Farmington Avenue, Farmington, CT 06030 Phone: 860-679-2980 Fax: 860-679-4334 | |
Andrew Arnold, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-3245 Fax: 860-679-1867 | |
Dr. Neelam Tailor, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Avenue, Farmington, CT 06030 Phone: 860-679-4763 Fax: 860-479-4624 | |
Dr. David K. Bowers, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 263 Farmington Ave, Farmington, CT 06032 Phone: 860-679-4477 Fax: 860-679-1025 | |
Scott R Allen, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-4477 Fax: 860-679-1025 | |
Carl D Malchoff, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-3245 Fax: 860-679-1867 | |
Beatriz R Esayag-tendler, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-3343 Fax: 860-679-4256 |